跳至主要内容
临床试验/NCT05937282
NCT05937282招募中4 期

Comparative Study Between the Hemodynamic Responses of Dexmedetomidine, Lidocaine or Propofol Infusions During Laparoscopic Cholecystectomy

Menoufia University1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2023年7月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
招募中
入组人数
80
试验地点
1
主要终点
Noninvasive mean blood pressure

研究概览

简要总结

This study will be carried out to compare the efficacy of dexmedetomidine, propofol or lidocaine infusions in attenuation of hemodynamic responses to pneumoperitoneum during adult laparoscopic cholecystectomy using electrical cardiometry.

详细描述

Many drug infusions have been used to control hemodynamic responses to laparoscopic surgeries like propofol, fentanyl, esmolol with varying degrees of success.

Dexmedetomidine has sedative and analgesic properties seems to be appropriate enough to control the sympathetic response as well as provide a stable hemodynamics

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • American Society of Anesthesiologists I patients.
  • Patients between the ages of ≥ 20 and ≤ 60 years of both sexes.

排除标准

  • Hypersensitivity to dexmedetomidine, propofol or lidocaine.
  • Diabetic patients (Hemoglobin A1C ≥ 7).
  • Hypertensive patients (Blood presssure ≥ 140/90 mmHg) or patients on medications that affect hemodynamics as clonidine, methyldopa, β blockers and calcium channel blockers.
  • Impaired liver function (serum albumin ≤ 3.5 g/dl, International normalized ratio≥ 1.3, total bilirubin >1mg/dl).
  • Impaired renal function (serum creatinine >1.2 mg/dl, blood urea >20mg/dl).
  • Morbidly obese patients with body mass index ≥
  • Patients with acute cholecystitis or active infection.
  • Patients taking medications that may impair cognition.
  • History of seizures.

研究组 & 干预措施

Control group

Placebo Comparator

Patients will receive infusion of 25 ml normal saline in 50 ml syringe pump.

干预措施: normal saline (Drug)

Dexmedetomidine group

Active Comparator

Patients will receive infusion of dexmedetomidine in the dose of 0.4 μg/kg/hr. One ml dexmedetomidine (100 μg/ml) will be diluted with 24 ml normal saline in 50 ml syringe pump to achieve dilution of 4 μg/ml.

干预措施: Dexmedetomidine (Drug)

Propofol

Active Comparator

Patients will receive propofol infusion in the dose of 3 mg/kg/hr. (12) 25 ml propofol 1% (10 mg /ml) in 50 ml syringe pump

干预措施: Propofol (Drug)

Lidocaine

Active Comparator

Patients will receive lidocaine infusion in the dose of 2 mg /kg/hr. (15) 25 ml lidocaine 1% (10 mg/ml) in 50 ml syringe pump.

干预措施: Lidocain (Drug)

结局指标

主要结局

Noninvasive mean blood pressure

时间窗: Intraoperatively

mean blood pressure will be noted by a standard automated multi channel monitor will be connected to each patient

次要结局

  • Intraoperative rescue drugs(Intraoperatively)
  • Post extubation sedation(24 hour postoperatively)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ahmed Mohammed Nasar

Specialist

Menoufia University

研究点 (1)

Loading locations...

相似试验